Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Regeneron Pharmaceuticals, Inc. (REGN) stock news and headlines to help you in your trading and investing decisions.

Interactive Chart for Regeneron Pharmaceuticals, Inc. (REGN), analyze all the data with a huge range of indicators.

See the company profile for Regeneron Pharmaceuticals, Inc. (REGN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...

Feb 29, 2024 · So, based on the above formula, the ROE for Regeneron Pharmaceuticals is: 15% = US$4.0b ÷ US$26b (Based on the trailing twelve months to December 2023). The 'return' is …

Discover historical prices for REGN stock on Yahoo Finance. View daily, weekly or monthly format back to when Regeneron Pharmaceuticals, Inc. stock was issued.

Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Sep 25, 2023 · Following its acceptance of the tendered shares, Regeneron completed its acquisition of Decibel through a second step merger of Symphony Acquisition Sub, Inc., with and into Decibel.

Apr 10, 2024 · Today we will run through one way of estimating the intrinsic value of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by projecting its future cash flows and then discounting them to today's value ...

Jan 30, 2024 · Regeneron Pharmaceuticals, Inc. Regeneron to assume full development and commercialization rights for 2seventy bio’s preclinical and clinical stage cell therapy pipeline